RT Journal Article
SR Electronic
T1 Epidemiological Analysis of Confirmed Mpox Cases in Burundi, July to September 2024
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.27.24314511
DO 10.1101/2024.09.27.24314511
A1 Nizigiyimana, Alexis
A1 Ndikumwenayo, Francois
A1 Manirakiza, Martin
A1 van Lettow, Monique
A1 Chan, Adrienne K.
A1 Liesenborghs, Laurens
A1 Mbala-Kingebeni, Placide
A1 Rimoin, Anne W.
A1 Bogoch, Isaac I.
A1 Kindachuk, Jason
YR 2024
UL http://medrxiv.org/content/early/2024/09/28/2024.09.27.24314511.abstract
AB This study analyzes mpox cases in Burundi from July to September 2024, following the introduction of Clade Ib. During this time, 25.4% of 607 samples tested positive via PCR. Children under 15 comprised 55.2% of cases, with a higher proportion of female children testing positive. Geographic analysis demonstrates case concentration in Bujumbura Mairie (59.1%). These findings highlight the importance of age- and sex-specific interventions for outbreak containment and the need for targeted public health strategies in Burundi.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for the work presented was provided by the International Mpox Research Consortium 188 (IMReC) through funding from the Canadian Institutes of Health Research and International 189 Development Research Centre (grant no. MRR-184813). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data was provided by country-wide mpox surveillance program. Permission to use this data was granted by the Institutional Ethics Committee at the Faculty of Medicine, University of Burundi (CIEB-FMCHUK no. 02/09/2024).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors